LifeMD, Inc. SEC filings LFMDP

LifeMD, Inc. has 578 filings in SEC EDGAR's recent list, going back to May 17, 2012. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

LifeMD, Inc. SEC filings
Form Description Filed Period
NT 10-Q Filing Nov 12, 2025 Sep 30, 2025
UPLOAD Letter from the SEC Feb 14, 2025 —
CORRESP Letter to the SEC Jan 31, 2025 —
UPLOAD Letter from the SEC Jan 17, 2025 —
CORRESP Letter to the SEC Dec 12, 2024 —
UPLOAD Letter from the SEC Nov 22, 2024 —
CORRESP Letter to the SEC Oct 25, 2024 —
UPLOAD Letter from the SEC Oct 16, 2024 —
EFFECT Filing Jul 18, 2024 —
EFFECT Filing Jul 18, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
UPLOAD Letter from the SEC Jun 17, 2024 —
UPLOAD Letter from the SEC Jun 10, 2024 —
DEFR14A Filing May 24, 2024 —
EFFECT Filing Jul 7, 2022 —
EFFECT Filing May 2, 2022 —
CERT Filing Oct 4, 2021 —
8-A12B Filing Oct 4, 2021 —
EFFECT Filing Aug 2, 2021 —
CORRESP Letter to the SEC Jul 30, 2021 —
UPLOAD Letter from the SEC Jul 29, 2021 —
EFFECT Filing Jun 22, 2021 —
CORRESP Letter to the SEC Jun 17, 2021 —
UPLOAD Letter from the SEC Jun 15, 2021 —
EFFECT Filing May 24, 2021 —
CORRESP Letter to the SEC May 20, 2021 —
UPLOAD Letter from the SEC May 5, 2021 —
EFFECT Filing Dec 31, 2020 —
CORRESP Letter to the SEC Dec 29, 2020 —
CERT Filing Dec 9, 2020 —
8-A12B Filing Dec 9, 2020 —
UPLOAD Letter from the SEC Dec 7, 2020 —
CORRESP Letter to the SEC Dec 3, 2020 —
PRER14A Filing Dec 3, 2020 —
UPLOAD Letter from the SEC Dec 2, 2020 —
UPLOAD Letter from the SEC Nov 30, 2020 —
PRER14A Filing Nov 25, 2020 —
CORRESP Letter to the SEC Nov 24, 2020 —
D Filing Nov 20, 2020 —
UPLOAD Letter from the SEC Oct 29, 2020 —
D Filing Sep 8, 2020 —
D Filing Sep 8, 2020 —
NT 10-Q Filing May 15, 2020 Mar 31, 2020
NT 10-Q Notification of late filing Aug 14, 2018 Jun 30, 2018
EFFECT Filing Jul 10, 2018 —
CORRESP Letter to the SEC Jul 9, 2018 —
UPLOAD Letter from the SEC Jul 9, 2018 —
8-A12G Form for registration of a class of securities Oct 16, 2017 —
D Filing Jul 31, 2017 —
NT 10-Q Notification of late filing Jun 7, 2017 Mar 31, 2017
NT 10-K Notification of late filing Mar 31, 2017 Dec 31, 2016
EFFECT Filing Feb 7, 2013 —
CT ORDER Filing Feb 7, 2013 —
CORRESP Letter to the SEC Feb 5, 2013 —
UPLOAD Letter from the SEC Dec 26, 2012 —
UPLOAD Letter from the SEC Nov 15, 2012 —
D/A Filing May 17, 2012 —
D Filing May 17, 2012 —

Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
LFMD (Nasdaq), LFMDP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Accelerated filer
SEC CIK
948320
Former names
CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.